Happy to see so many brilliant works at the hashtag#MIDL conference in Paris! It's a fantastic opportunity to connect with colleagues and graduates passionate about medical imaging and deep learning.
I was invited to give a Keynote Lecture on AI in Ophthalmology and Pathology to present a few works on Histopathology; Mitotoc figure detection in Breast Cancer, Domain Adaptation from H&E Imaging to IHC imaging among others. Thanks Prof. Martina C. Herwig-Carl for the invitation and warm hospitality!
Our lab at Universitätsklinikum Bonn, The University of Bonn, and Helmholtz AI in cooperation with the Arab-German Young Academy of Sciences and Humanities (AGYA) are delighted to announce the upcoming AGYA Summer School on Affordable Artificial Intelligence (SAAI -سعي) in Bonn, 22-26 July 2024.
I have just completed the research visit at the University of Sharjah, NYU Abu Dhabi, and other esteemed universities. This initiative aims to strengthen connections and foster collaboration between German and Emirati academic institutes in the field of health and medical sciences. I will soon return to the Emirates to organize a one-day workshop on AI and healthcare at a prestigious academic institute. Stay tuned for more details!
Abstract. Our project aims to improve the diagnosis of Inherited Retinal Dystrophies (IRDs), a group of rare retinal diseases impacting over 2 million people globally [1]. IRDs can lead to vision problems like night blindness, color blindness, tunnel vision, and eventual blindness, greatly affecting patients’ and their families’ quality of life [4].
Abstract. Giant cell arteritis (GCA) is a systemic autoimmune disease marked by inflammation of blood vessels (“vasculitis”) that can cause impairment and damage to organs [1]. GCA typically affects large and medium size arteries, such as the aorta and the temporal and axillary arteries [2–4].
I was excited to join a distinguished panel, including Prof. Dr. Wolfgang Böcker, Prof. Dr. Clemens Cyran, and Katharina Danhauser, moderated by Claus Belka, to explore AI's readiness for clinical routine. Our discussion spotlighted crucial aspects: the current state of AI in clinics and strategic placement within workflows. Emphasis was placed on robust data governance and addressing development challenges. The dialogue highlighted the importance of collaboration with stakeholders, involving regulatory bodies, and prioritizing education and training. Grateful for the opportunity to contribute to this pivotal conversation shaping the future of AI in healthcare. Thanks for the invitation, Guillaume Landry!